0001104659-22-071895.txt : 20220616
0001104659-22-071895.hdr.sgml : 20220616
20220616161149
ACCESSION NUMBER: 0001104659-22-071895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHWARTZ BRIAN
CENTRAL INDEX KEY: 0001431322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50626
FILM NUMBER: 221020681
MAIL ADDRESS:
STREET 1: C/O ARQULE, INC.
STREET 2: 1 WALL STREET, 6TH FLOOR
CITY: BURLINGTON
STATE: MA
ZIP: 01803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001130166
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911766850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-7330
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
FORMER COMPANY:
FORMER CONFORMED NAME: XCYTE THERAPIES INC
DATE OF NAME CHANGE: 20001218
4
1
tm2218645-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-14
0
0001130166
Cyclacel Pharmaceuticals, Inc.
CYCC
0001431322
SCHWARTZ BRIAN
C/O CYCLACEL PHARMACEUTICALS, INC.,
200 CONNELL DRIVE, SUITE 1500
BERKELEY HEIGHTS
NJ
07922
1
0
0
0
Common Stock
2022-06-14
4
A
0
15822
0
A
19383
D
Stock Option (right to buy)
1.11
2022-06-14
4
A
0
31645
0
A
2023-06-14
2032-06-14
Common Stock
31645
31645
D
The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023.
These options were granted to Dr. Schwartz for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.
/s/ Brian Schwartz
2022-06-16